DNA Ginkgo Bioworks Holdings, Inc.

NYSE
$8.32

Ginkgo Bioworks Holdings, Inc. (DNA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with DNA's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
9 transactions
Purchases
$0
0 shares
Sales
$1.4M
136,525 shares
Net activity
-$1.4M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $1.4M 9 transactions · 136,525 shares

Largest single sale: $463.4K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kelly Jason R See remarks Sell 45,682 $10.14 $463.4K 129,065 −26.1% of holding
Shetty Reshma P. 2 fills See remarks Sell 41,172 $10.14 $417.6K 453,951 −8.3% of holding
Canton Barry 2 fills 10% Owner Sell 41,172 $10.14 $417.6K 453,951 −8.3% of holding
Coen Steven P. See remarks Sell 766 $10.14 $7.8K 50,168 −1.5% of holding
Coen Steven P. See remarks Sell 2,403 $15.00 $36.0K 49,448 −4.6% of holding
HENRY CHRISTIAN O Director Sell 5,000 $7.08 $35.4K 19,310 −20.6% of holding
Coen Steven P. See remarks Sell 330 $6.98 $2.3K 51,851 −0.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.